NetJets Empowers Pilots With Cutting-Edge Safety Analytics From FlightPulse ®
29.7.2025 16:05:00 EEST | Business Wire | Press release
Recognized worldwide for its safety-first focus, NetJets, the global private aviation leader, today announced the adoption of FlightPulse® from GE Aerospace across its operations in the United States and Europe, providing pilots with data to increase safety and efficiency from takeoff to landing.
FlightPulse® will equip NetJets’ more than 4,400 pilots globally with secure, consolidated flight data to drive informed decisions on risk management, aircraft functionality and fuel, and their own performance, fostering continuous self-improvement. NetJets is the first private jet operator of its kind to embrace the technology, which it plans to begin deploying by the end of the year.
“In the world of aviation, safety is paramount and will always be NetJets’ first and highest priority, integral to every decision we make,” said Adam Johnson, NetJets Chairman and CEO. “As the industry leader, it is our responsibility to elevate our safety programs by utilizing cutting-edge tools like FlightPulse® to continue to bring best-in-class service to our customers worldwide.”
Designed by pilots, for pilots, FlightPulse® is a fully configurable, modular Electronic Flight Bag (EFB) application. By putting important operational data directly in the hands of pilots, FlightPulse® empowers aviators to make more informed decisions, self-critique recent flight profiles, and compare themselves to their peers. FlightPulse® offers integrated pre- and postflight modules that deliver essential safety and sustainability insights about flight paths that help pilots bolster their flying performance.
As an extension of GE Aerospace’s Flight Operations Quality Assurance (FOQA) program, FlightPulse® enables operators to provide crewmembers with rapid feedback on flight performance and insights to enhance safety and aid decision-making. On any given day, FlightPulse® processes data from an average of 2.5 million flights, providing pilots with comprehensive, data-driven insights to support safer and more efficient operations.
"We are proud to collaborate with NetJets as they adopt GE Aerospace’s FlightPulse® software to enhance pilot decision-making and operational performance,” said Andrew Coleman, President and General Manager, GE Aerospace’s Software as a Service. “This collaboration marks a significant milestone, expanding the global reach of business jet pilots using our software. Together, we are helping to drive innovation and safety in aviation by providing pilots with actionable, data-driven insights to optimize every flight."
Similar to its implementation of FlightPulse®, NetJets was the first shared ownership provider to establish a FOQA program, which has successfully produced actionable discoveries and strengthened safety margins. FlightPulse® is one of NetJets’ newest tools to support its enduring efforts to elevate safety for pilots and passengers.
About NetJets
Originally incorporated in 1964 as Executive Jet Airways, NetJets has been setting—and exceeding—industry standards for more than 60 years. Today, NetJets is proud to be a Berkshire Hathaway company known for its unwavering commitment to safety and service. The NetJets portfolio of distinctive companies, encompassing NetJets, Executive Jet Management, QS Partners, and QS Security, offers a variety of customizable travel solutions, including shared ownership, lease and jet card options, aircraft management, private jet chartering, brokerage and acquisition services, and specialized security services. This comprehensive suite of solutions is why so many of the world’s most discerning travelers choose NetJets generation after generation. It is also because NetJets has the largest, most diverse private jet fleet in the world, which grants anytime access to even the most remote destinations across the globe. To learn more about the leader in private aviation, visit netjets.com today.
About GE Aerospace
GE Aerospace is a global aerospace propulsion, services, and systems leader with an installed base of approximately 49,000 commercial and 29,000 military aircraft engines. With a global team of approximately 53,000 employees building on more than a century of innovation and learning, GE Aerospace is committed to inventing the future of flight, lifting people up, and bringing them home safely. Learn more about how GE Aerospace and its partners are defining flight for today, tomorrow and the future at www.geaerospace.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250728889622/en/
Contacts
Media Contacts:
NetJets Press Team
NetJetsPress@apcoworldwide.com
GE Aerospace
Todd Alhart, Director, Innovation Communications
Todd.Alhart@geaerospace.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom